Surface Logix Inc. Company Profile

23:58 EDT 21st June 2018 | BioPortfolio

Surface Logix Inc. uses its expertise in biophysical chemistry to create new small molecule drugs that are optimized to meet the challenges of human physiology. The company is advancing multiple internal programs focused primarily on cardiovascular, metabolic, inflammatory and fibrotic diseases


50 Soldiers Field Place
United States of America


Phone: 617.746.8500
Fax: 617.783.8877

News Articles [285 Associated News Articles listed on BioPortfolio]

Microsoft stellt Surface Hub 2 vor

SAN FRANCISCO (IT-Times) - Der US-Softwarekonzern Microsoft Corp. hat mit dem Surface Hub 2 eine neue und zweite Version des digitalen Flipcharts Surface Hub präsentiert. Das Surface Hub 2 ist eine.....

Surface Oncology closes $11.5mm PIPE concurrent with IPO

Surface Oncology Inc. (cancer immunotherapies) grossed $11.5mm through a private placement of 766,666 common shares at $15 apiece to Novartis Institutes for BioMedical Research. The PIPE closed concur...

The far-reaching effects of ocean floors on the sea surface

Low rises on the ocean floor at a depth of 5,500 meters in the western North Pacific regulate surface flows and create sharp sea surface temperature (SST) fronts, which have tremendous effects on the ...

TECHSPEC® Low Scatter Off-Axis Parabolic Mirrors Exhibit Less than 50 Ångström RMS Surface Roughness

Providing a surface figure of λ/8 RMS and a surface roughness of less than 50Å RMS, these precision mirrors are designed for low scatter in the visible spectrum

Surface Oncology Promotes Goater to CEO, Lynch Remains Chairman

Jeff Goater, chief business officer of Surface Oncology, has been appointed CEO of the company. Goater replaces interim CEO Dan Lynch, who will remain executive chairman of the Cambridge, MA, company...

Cambridge's Surface Oncology Promotes CBO to Top Job

Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors.

Surface Oncology Plans IPO to Advance Clinical Tests of Cancer Drug

Cancer continues to be a big area of investor interest and Surface Oncology now aims to tap into that with an initial public stock offering that the company hopes will finance tests of its lead immuno...

Surface Oncology’s Upsized IPO Reels in $108M for Lead Cancer Drug

Surface Oncology has raised $108 million from an initial public offering to finance clinical testing of its lead cancer immunotherapy. Cambridge, MA-based Surface priced its offering of 7.2 million sh...

PubMed Articles [1429 Associated PubMed Articles listed on BioPortfolio]

Surface plasmon of three-dimensional Dirac semimetals.

The surface plasmon excitation spectrum is calculated for the semi-infinite three-dimensional Dirac semimetal. We used the random phase approximation (RPA) for the calculation of the surface dielectri...

Surface forces between highly charged cationic polyelectrolytes adsorbed to silica: how control of pH and the adsorbed amount determines the net surface charge.

Atomic force microscopy (AFM) and quartz crystal microbalance with dissipation (QCM-D) were employed to investigate the pH dependent adsorption of poly(diallyl dimethyl ammonium chloride) (polyDADMAC)...

Atomic structure and passivated nature of the Se-treated GaAs(111)B surface.

We have systematically studied the atomic structure and electronic properties of the Se-treated GaAs(111)B surface using scanning tunneling microscopy, reflection high-energy electron diffraction, x-r...

Surface Zn doped LiMnO for an improved high temperature performance.

A surface doping strategy is demonstrated for the stabilization of LiMn2O4, which is achieved by the surface solid reaction between the LiMn2O4 particle and its ZnO nanoshell. The surface treated samp...

Structural Origin of Enhanced Dynamics at the Surface of a Glassy Alloy.

The enhancement of mobility at the surface of an amorphous alloy is studied using a combination of molecular dynamic simulations and normal mode analysis of the nonuniform distribution of Debye-Waller...

Clinical Trials [871 Associated Clinical Trials listed on BioPortfolio]

Surface Roughness of a Dental Restorative Material and Biofilm Formation

In this study we intend to find out the pattern of biofilm accumulation in vivo on various surface finishings. Our intention is to prepare Polymethylmetacrylate squers on orthodontical br...

French National Registry of Rare Peritoneal Surface Malignancies

Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patien...

Ultrasound Comparison of the Surface of the Subclavian and the Axillary Vein Versus the Surface of the Subclavian Vein

The main objective of this study is the demonstration of an increase of over 50% of the surface visible on ultrasound (mm2) of the axillary vein and subclavian vein in arm abduction (90 °...

A Comparison of Two Metal Surface Finishes on Femoral Components in Hip Arthroplasty

The purpose of this study is to compare metal surface finishes (proximal-coated titanium surface versus mid-coated titanium surface) on femoral components in hip arthroplasty.

Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

Severe dry eye is a debilitating ocular disease resulting in loss of vision, reduced day-to-day function and significant discomfort. Tear substitutes are an important part of the treatment...

Companies [207 Associated Companies listed on BioPortfolio]

Surface Logix Inc.

Surface Logix Inc. uses its expertise in biophysical chemistry to create new small molecule drugs that are optimized to meet the challenges of human physiology. The company is advancing multiple inter...


Visualizing Protein Complexes• A Pair of Polyhedra• Surface Buried in an Interface• Computing a Surface Between Two Densities• Polyhedra Evaluated at an Interfacial Surface• Densities Evalua...

EOS Surfaces, LLC

EOS Surfaces, LLC is a solid surface manufacturer, founded in 2005, which revolutionized the solid surface industry with the first 3cm surface, a change from most ½” solid...

Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of ca...

Titan Spine, LLC

Titan Spine, LLC is a surface technology company focused on the design and manufacture of interbody fusion devices for the spine. The company is committed to advancing the science...

More Information about "Surface Logix Inc." on BioPortfolio

We have published hundreds of Surface Logix Inc. news stories on BioPortfolio along with dozens of Surface Logix Inc. Clinical Trials and PubMed Articles about Surface Logix Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Surface Logix Inc. Companies in our database. You can also find out about relevant Surface Logix Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record